UNSPSC 51172157: Adiphenine methyl bromide

This classification denotes an antispasmotic agent with the molecular formula C21H28NO2.Br, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2OVU84VI37, chemically known as acetic acid, diphenyl-, ester with diethyl(2-hydroxyethyl)methylammonium bromide, but more generally known as adiphenine methyl bromide, which bears US NIH Compound Identifier 197841. European Medicines Agency schedules adiphenine methyl bromide or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05272MIG.

Most nations, for tariff purposes, schedule adiphenine methyl bromide under HS 29221980. SMILES: CC[N+](C)(CC)CCOC(=O)C(C1CCCCC1)C2CCCCC2.[BR-].

UNSPSC 51172157 Adiphenine methyl bromide is a Commodity code with minimal concrete recent activity tied to its nominal pharmaceutical scope. The recent state and local opportunities tagged under this code do not solicit adiphenine methyl bromide or related anticholinergic agents directly. Instead, they reflect broader pharmacy and specimen-collection procurement activity within state corrections and public health agencies. Collin County's RFP 2026-327 for offender specimen collection and drug testing services, due July 23, 2026, encompasses lab certification, immunoassay screening, LC/MS/MS confirmation, and oral-fluid and hair-testing methodologies—none of which involve adiphenine as an active procurement target. The Texas HHS Commission's RFI HHS0017013 on direct-to-manufacturer prescriptions and the Minnesota MMCAP RFP S1070000015802 for generic multi-source pharmaceuticals and OTC products are broad-based pharmacy benefit and pharmaceutical supply chain initiatives, not specific to this Commodity code's nominal product line.

The geographic spread of recent activity centers on Texas (Collin County and the state HHS Commission) and Minnesota (MMCAP, serving multiple state and local government facilities including Oregon). The Collin County RFP, with an estimated contract value of $600,000 and a two-year base term commencing September 1, 2026, represents the most directly relevant solicitation in the recent record, though it targets drug-testing services procurement rather than adiphenine supply. The code shows no targeted recent solicitations for adiphenine methyl bromide or related active pharmaceutical ingredients within state and local government procurement. A business development professional should verify whether this code misclassification reflects a data-tagging issue or signals that state and local demand for this specific compound is currently inactive or handled through alternative procurement vehicles.